F2R and melanoma: PAR-1 overexpression has been found in breast, melanoma, renal, gastric, colon, lung, pancreatic, esophageal, prostate, liver, ovarian, endometrial, head and neck cancers [27, 43, 46–47, 63–69] (Suppplementary Table 1, Figure 3).